Efficacy of RG7787, a next-generation mesothelin-targeted immunotoxin, against triple-negative breast and gastric cancers von Alewine, Christine, Xiang, Laiman, Yamori, Takao, Niederfellner, Gerhard, Bosslet, Klaus, Pastan, Ira

Volltext

RG7386, a Novel Tetravalent FAP-DR5 Antibody, Effectively Triggers FAP-Dependent, Avidity-Driven DR5 Hyperclustering and Tumor Cell Apoptosis von Brünker, Peter, Wartha, Katharina, Friess, Thomas, Grau-Richards, Sandra, Waldhauer, Inja, Koller, Claudia Ferrara, Weiser, Barbara, Majety, Meher, Runza, Valeria, Niu, Huifeng, Packman, Kathryn, Feng, Ningping, Daouti, Sherif, Hosse, Ralf J, Mössner, Ekkehard, Weber, Thomas G, Herting, Frank, Scheuer, Werner, Sade, Hadassah, Shao, Cuiying, Liu, Bin, Wang, Peng, Xu, Gary, Vega-Harring, Suzana, Klein, Christian, Bosslet, Klaus, Umaña, Pablo

Volltext

Dual IGF-I/II-Neutralizing Antibody MEDI-573 Potently Inhibits IGF Signaling and Tumor Growth von JIN GAO, CHESEBROUGH, Jon W, COATS, Steven, BOSSLET, Klaus, CHANG, Yong S, CARTLIDGE, Susan A, RICKETTS, Sally-Ann, INCOGNITO, Leonard, VELDMAN-JONES, Margaret, BLAKEY, David C, TABRIZI, Mohammad, JALLAL, Bahija, TRAIL, Pamela A

Volltext

Characterization of a re-engineered, mesothelin-targeted Pseudomonas exotoxin fusion protein for lung cancer therapy von Bauss, Frieder, Lechmann, Martin, Krippendorff, Ben-Fillippo, Staack, Roland, Herting, Frank, Festag, Matthias, Imhof-Jung, Sabine, Hesse, Friederike, Pompiati, Marc, Kollmorgen, Gwendlyn, da Silva Mateus Seidl, Rita, Bossenmaier, Birgit, Lau, Wilma, Schantz, Christian, Stracke, Jan O., Brinkmann, Ulrich, Onda, Masanori, Pastan, Ira, Bosslet, Klaus, Niederfellner, Gerhard

Volltext

Abstract 4510: RG7787 - a novel de-immunized PE based fusion protein for therapy of mesothelin-positive solid tumors von Niederfellner, Gerhard, Bauss, Frieder, Imhof-Jung, Sabine, Hesse, Friederike, Kronenberg, Sven, Staak, Roland, Lechmann, Martin, Krippendorff, Ben, Richter, Wolfgang, Mateus, Rita, Kollmorgen, Gwendlyn, Brinkmann, Ulli, Onda, Masanori, Pastan, Ira, Bosslet, Klaus

Volltext

Molecular and pharmacodynamic characteristics of the novel multi-target tumor growth inhibitor ZK 304709 von Siemeister, G., Luecking, U., Wagner, C., Detjen, K., Mc Coy, C., Bosslet, Klaus

Volltext

Monoclonal antibody BW835 defines a site-specific Thomsen-Friedenreich disaccharide linked to threonine within the VTSA motif of MUC1 tandem repeats von Hanisch, F G, Stadie, T, Bosslet, K

Volltext

Abstract B69: Novel MHC class I antibody fusions for cancer treatment von Schmittnaegel, Martina, Hoffmann, Eike, Mundigl, Olaf, Niederfellner, Gerhard, Bosslet, Klaus, Umana, Pablo, Levitsky, Victor, Klein, Christian, Knoetgen, Hendrik

Volltext

Abstract 1757: MEDI-573, an IGF-I/II neutralizing human antibody inhibits both IGF-1R and IR-A signaling pathways von Gao, Jin, Chesebrough, Jon W., Incognito, Leonard, Coats, Steven, Bosslet, Klaus, Jallal, Bahija, Chang, Yong S.

Volltext

Elucidation of the mechanism enabling tumor selective prodrug monotherapy von BOSSLET, K, STRAUB, R, BLUMRICH, M, CZECH, J, GERKEN, M, SPERKER, B, KROEMER, H. K, GESSON, J.-P, KOCH, M, MONNERET, C

Volltext

RADIOIMMUNOCONJUGATE FOR USE IN TREATING BONE MARROW ASSOCIATED DISEASES von ORCHARD, Kim, BOSSLET, Klaus

Volltext bestellen

RADIOIMMUNOCONJUGATE FOR USE IN TREATING BONE MARROW ASSOCIATED DISEASES von ORCHARD, Kim, BOSSLET, Klaus

Volltext bestellen

RADIOIMMUNOCONJUGATE FOR USE IN TREATING BONE MARROW ASSOCIATED DISEASES von ORCHARD, Kim, BOSSLET, Klaus

Volltext bestellen

Simultaneous high-performance liquid chromatographic determination of a glucuronyl prodrug of doxorubicin, doxorubicin and its metabolites in human lung tissue von Mürdter, Thomas E, Sperker, Bernhard, Bosslet, Klaus, Fritz, Peter, Kroemer, Heyo K

Volltext

Expression of CD66 in non-Hodgkin lymphomas and multiple myeloma: Letter to the Editor von Guinn, Barbara-Ann, Bosslet, Klaus, Lee, Cindy, Richardson, Deborah, Orchard, Kim

Volltext

Expression of CD66 in non-Hodgkin lymphomas and multiple myeloma von Guinn, Barbara-Ann, Bosslet, Klaus, Lee, Cindy, Richardson, Deborah, Orchard, Kim

Volltext

RADIOIMMUNOCONJUGATE FOR USE IN TREATING BONE MARROW ASSOCIATED DISEASES von ORCHARD, Kim, BOSSLET, Klaus

Volltext bestellen

Tumor-selective prodrug activation by fusion protein-mediated catalysis von BOSSLET, K, CZECH, J, HOFFMANN, D

Volltext

RADIOIMMUNOCONJUGATE FOR USE IN TREATING BONE MARROW ASSOCIATED DISEASES von ORCHARD, Kim, BOSSLET, Klaus

Volltext bestellen

Radioimmunoconjugate for use in treating bone marrow associated diseases von Orchard, Kim, Bosslet, Klaus

Volltext bestellen